| Literature DB >> 34225771 |
Lusine Yaghjyan1, Rebecca J Austin-Datta2, Hannah Oh3,4, Yujing J Heng5, Adithya D Vellal5, Korsuk Sirinukunwattana5,6, Gabrielle M Baker5, Laura C Collins5, Divya Murthy7, Bernard Rosner7, Rulla M Tamimi8.
Abstract
BACKGROUND: We investigated the associations of reproductive factors with the percentage of epithelium, stroma, and fat tissue in benign breast biopsy samples.Entities:
Keywords: Age at first child; Benign breast disease; Breast cancer risk; Breastfeeding; Parity
Mesh:
Year: 2021 PMID: 34225771 PMCID: PMC8258947 DOI: 10.1186/s13058-021-01447-2
Source DB: PubMed Journal: Breast Cancer Res ISSN: 1465-5411 Impact factor: 6.466
Age-adjusted characteristics of women at the time of the biopsy, stratified by menopausal status and parity
| Characteristic | Premenopausal, n = 601 | Postmenopausal, n = 290 | ||
|---|---|---|---|---|
| Nulliparous, n = 61 | Parous, n = 540 | Nulliparous, n = 21 | Parous, n = 269 | |
| Mean (SD) | ||||
| % epithelium | 8.8 (4.8) | 10.4 (7.0) | 4.6 (2.8) | 7.2 (6.1) |
| % stroma | 76.1 (10.3) | 74.5 (11.0) | 74.0 (10.7) | 67.3 (12.6) |
| % fat | 15.1 (11.2) | 15.1 (10.9) | 21.3 (9.9) | 25.5 (13.5) |
| % fibroglandular tissuea | 84.9 (11.2) | 84.9 (10.9) | 78.7 (9.9) | 74.5 (13.5) |
| Age (years)b | 36.2 (7.4) | 41.5 (7.3) | 55.1 (7.5) | 57.3 (6.5) |
| Age at menopause (years) | NA | NA | 44.5 (4.9) | 48.4 (5.1) |
| Body mass index (kg/m2) | 24.2 (5.4) | 24.1 (4.5) | 24.5 (2.4) | 25.1 (4.0) |
| Alcohol use (g/day) | 4.2 (4.7) | 5.4 (8.8) | 4.3 (3.8) | 5.5 (8.6) |
| Parity | NA | 2.7 (1.2) | NA | 3.2 (1.5) |
| Age at first birth (years) | NA | 25.1 (3.6) | NA | 24.9 (3.2) |
| Age at menarche (years) | 13.0 (1.1) | 12.5 (1.4) | 12.9 (0.8) | 12.7(1.3) |
| Percentagesc | ||||
| Breastfeeding | ||||
| 0 to < 1 month | NA | 41 | NA | 50 |
| 1 to < 12 months | NA | 32 | NA | 37 |
| 12 to < 24 months | NA | 18 | NA | 10 |
| ≥ 24 months | NA | 10 | NA | 3 |
| Family history of breast cancer | 10 | 10 | 22 | 17 |
| Smoking status | ||||
| Never smoked | 61 | 56 | 24 | 49 |
| Past smoker | 20 | 28 | 45 | 34 |
| Current smoker | 20 | 16 | 31 | 17 |
| Postmenopausal hormone use | ||||
| Never used | NA | NA | 12 | 29 |
| Past use | NA | NA | 3 | 21 |
| Current use | NA | NA | 74 | 32 |
| Unknown status | NA | NA | 12 | 18 |
| Benign breast disease subtypes | ||||
| Non-proliferative | 23 | 32 | 39 | 27 |
| Proliferative without atypia | 70 | 58 | 45 | 55 |
| Proliferative with atypia | 7 | 10 | 15 | 18 |
Note: Values are means (SD) and percentages and are standardized to the age distribution of the study population
Abbreviations: SD standard deviation, NA not applicable
aFibroglandular tissue represents combined epithelium and stroma
bValue is not age adjusted
cPercentages are calculated based on non-missing values
Associations of reproductive variables with the percentage of different tissue types (log-transformed) in benign breast biopsy samples (β coefficients and 95% confidence intervals)
| Reproductive factor | Number | Tissue type | |||
|---|---|---|---|---|---|
| % epithelial | % stroma | % fat | % fibroglandulara | ||
| Nulliparityb | |||||
| Nulliparous | 86 | − 0.26 (− 0.41; − 0.11) | 0.04 (0.01; 0.08) | − 0.34 (− 0.54; − 0.13) | 0.01 (− 0.02; 0.05) |
| Parous | 880 | Ref | Ref | Ref | Ref |
| Breastfeeding, monthsc | |||||
| 0 to < 1 | 361 | Ref | Ref | Ref | Ref |
| 1 to < 12 | 279 | 0.03 (− 0.07; 0.13) | 0.02 (− 0.01; 0.04) | − 0.06 (− 0.18; 0.07) | 0.01 (− 0.01; 0.04) |
| 12 to < 24 | 119 | 0.08 (− 0.05; 0.22) | 0.01 (− 0.03; 0.04) | − 0.05 (− 0.22; 0.12) | 0.01 (− 0.03; 0.04) |
| ≥ 24 | 57 | 0.04 (− 0.15; 0.23) | 0.02 (− 0.03; 0.08) | − 0.30 (− 0.54; − 0.06) | 0.03 (− 0.02; 0.07) |
| p-trend | 816 | 0.39 | 0.43 | 0.04 | 0.34 |
| Parityd | |||||
| 1 | 82 | Ref | Ref | Ref | Ref |
| 2 | 292 | 0.11 (− 0.05; 0.27) | − 0.02 (− 0.06; 0.02) | − 0.05 (− 0.25; 0.15) | 0.01 (− 0.03; 0.05) |
| 3 | 269 | 0.12 (− 0.05; 0.28) | − 0.03 (− 0.08; 0.01) | 0.01 (− 0.19; 0.22) | − 0.01(− 0.05; 0.03) |
| ≥ 4 | 223 | 0.16 (− 0.02; 0.33) | − 0.05 (− 0.10; − 0.00) | 0.04 (− 0.18; 0.26) | − 0.02(− 0.06; 0.03) |
| p-trend | 866 | 0.13 | 0.02 | 0.32 | 0.17 |
| Parity continuousd | 866 | 0.03 (− 0.00; 0.07) | − 0.01 (− 0.02; − 0.00) | 0.01 (− 0.03; 0.06) | − 0.01 (− 0.01; 0.00) |
| Age at first child’s birthe | |||||
| < 25 | 445 | ref | ref | ref | ref |
| 25–29 | 331 | 0.12 (0.03; 0.21) | − 0.01 (− 0.03; 0.02) | − 0.09 (− 0.20; 0.03) | 0.01 (− 0.01; 0.03) |
| ≥ 30 | 90 | 0.07 (− 0.08; 0.23) | − 0.03 (− 0.07; 0.01) | − 0.04 (− 0.23; 0.15) | − 0.01 (− 0.05; 0.03) |
| p-trend | 866 | 0.13 | 0.16 | 0.44 | 0.85 |
| Age at first birth continuous (per 5 years)e | 866 | 0.04 (− 0.02; 0.11) | − 0.01 (− 0.02; 0.01) | − 0.03 (− 0.11; 0.05) | − 1.8 × 10−3 (− 0.01; 0.02) |
| Age at menarchef | |||||
| < 12 | 176 | − 0.09 (− 0.22; 0.04) | − 0.01 (− 0.05; 0.02) | 0.07 (− 0.12; 0.25) | − 0.01 (− 0.05; 0.02) |
| 12 | 275 | − 0.13 (− 0.24; − 0.01) | − 0.04 (− 0.07; − 0.01) | 0.10 (− 0.06; 0.26) | − 0.05 (− 0.07; − 0.02) |
| 13 | 287 | − 0.06 (− 0.17; 0.05) | − 0.03 (− 0.06; − 0.00) | − 0.01 (− 0.17; 0.15) | − 0.03 (− 0.05; − 0.00) |
| > 13 | 228 | ref | ref | ref | ref |
| p-trend | 966 | 0.07 | 0.23 | 0.24 | 0.11 |
| Age at menarche continuous (per 5 years)f | 966 | 0.15 (− 0.01, 0.30) | 0.02 (− 0.02, 0.06) | − 0.11 (− 0.33, 0.11) | 0.03 (− 0.01, 0.06) |
| Time between menarche and age at first birth, continuous (per 5 years)g | 866 | 0.02 (− 0.04; 0.08) | − 0.01 (− 0.02; 0.01) | − 0.01 (− 0.09; 0.06) | − 1.7 × 10−3 (− 0.02; 0.01) |
| Time since the last pregnancy, continuous (per 5 years)c | 839 | − 0.05 (− 0.12; 0.02) | − 0.02 (− 0.04 –3.0 × 10−3) | 0.05 (− 0.03; 0.14) | − 0.02 (− 0.04; − 3.0 × 10−3) |
aFibroglandular tissue represents combined epithelium and stroma
bAdjusted for age (continuous), BMI (continuous), age at menarche (< 12, 12, 13, > 13), a family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/no hormones, postmenopausal/past hormones, postmenopausal/current hormones, postmenopausal/unknown hormone use status), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥ 5 g/day)
cAmong parous women only: adjusted for age (continuous), BMI (continuous), age at menarche (< 12, 12, 13, > 13), parity, age at first child’s birth, a family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/no hormones, postmenopausal/past hormones, postmenopausal/current hormones, postmenopausal/unknown hormone use status), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
dAmong parous women only: adjusted for age (continuous), BMI (continuous), age at first birth, age at menarche (< 12, 12, 13, > 13), a family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/no hormones, postmenopausal/past hormones, postmenopausal/current hormones, postmenopausal/unknown hormone use status), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
eAmong parous women only: adjusted for age (continuous), BMI (continuous), parity, age at menarche (< 12, 12, 13, > 13), a family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/no hormones, postmenopausal/past hormones, postmenopausal/current hormones, postmenopausal/unknown hormone use status), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
fAdjusted for age (continuous), BMI (continuous), parous status (nulliparous, parous), a family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/no hormones, postmenopausal/past hormones, postmenopausal/current hormones, postmenopausal/unknown hormone use status), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
gAmong parous women only: adjusted for age (continuous), BMI (continuous), parity, a family history of breast cancer (yes/no), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/no hormones, postmenopausal/past hormones, postmenopausal/current hormones, postmenopausal/unknown hormone use status), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥ 5 g/day)
Associations of reproductive variables with the percentage of different tissue types (log-transformed) in benign breast biopsy samples of premenopausal women (β coefficients and 95% confidence intervals)
| Reproductive factor | Number | Tissue type | |||
|---|---|---|---|---|---|
| % epithelial | % stroma | % fat | % fibroglandulara | ||
| Nulliparityb | |||||
| Nulliparous | 61 | − 0.22 (− 0.38; − 0.06) | 0.06 (0.02; 0.10) | − 0.32 (− 0.56; − 0.08) | 0.03 (− 0.01; 0.06) |
| Parous | 540 | Ref | Ref | Ref | Ref |
| Breastfeeding, monthsc | |||||
| 0 to < 1 | 210 | Ref | Ref | Ref | Ref |
| 1 to < 12 | 162 | − 0.06 (− 0.18; 0.06) | 0.04 (0.01; 0.07) | − 0.11 (− 0.28; 0.06) | 0.03 (− 0.00; 0.05) |
| 12 to < 24 | 92 | − 0.02 (− 0.17; 0.13) | 0.01 (− 0.03; 0.06) | − 0.02 (− 0.24; 0.19) | 0.00 (− 0.03; 0.04) |
| ≥ 24 | 47 | − 0.09 (− 0.30; 0.11) | 0.04 (− 0.02; 0.09) | − 0.18 (− 0.48; 0.11) | 0.02 (− 0.02; 0.07) |
| p-trend | 511 | 0.53 | 0.33 | 0.39 | 0.57 |
| Parityd | |||||
| 1 | 62 | Ref | Ref | Ref | Ref |
| 2 | 190 | 0.27 (0.10; 0.44) | − 0.02 ( − 0.07; 0.03) | − 0.17 (− 0.42; 0.07) | 0.02 (− 0.02; 0.06) |
| 3 | 167 | 0.25 (0.08; 0.43) | − 0.04 (− 0.09; 0.01) | − 0.03 (− 0.29; 0.22) | − 0.00 (− 0.04; 0.04) |
| ≥ 4 | 108 | 0.34 (0.14; 0.53) | − 0.06 (− 0.11; − 0.00) | 0.03 (− 0.25; 0.30) | − 0.01 (− 0.05; 0.04) |
| p-trend | 527 | 0.01 | 0.02 | 0.25 | 0.23 |
| Parity continuousd | 527 | 0.07 (0.02; 0.11) | − 0.02 (− 0.03; − 0.00) | 0.03 (− 0.03; 0.10) | − 0.01 (− 0.02; 0.00) |
| Age at first child’s birthe | |||||
| < 25 | 263 | Ref | Ref | Ref | Ref |
| 25–29 | 205 | 0.20 (0.10; 0.31) | − 0.01 (− 0.04; 0.02) | − 0.19 (− 0.34; − 0.03) | 0.02 (− 0.01; 0.04) |
| ≥ 30 | 59 | 0.23 (0.06; 0.40) | − 0.05 (− 0.10; − 0.00) | 0.01 (− 0.24; 0.26) | − 0.01 (− 0.05; 0.03) |
| p-trend | 527 | < 0.01 | 0.05 | 0.58 | 0.99 |
| Age at first birth continuous (per 5 years)e | 527 | 0.10 (0.03; 0.17) | − 0.01 (− 0.03; 0.01) | − 0.04 (− 0.14; 0.06) | 4.5 × 10−3 (− 0.01; 0.02) |
| Age at menarchef | |||||
| < 12 | 115 | − 0.10 (− 0.25; 0.06) | − 0.01 (− 0.05; 0.03) | 0.10 (− 0.13; 0.33) | − 0.02 (− 0.05; 0.02) |
| 12 | 174 | − 0.14 (− 0.28; − 0.00) | − 0.03 (− 0.06; 0.01) | 0.07 (− 0.14; 0.28) | − 0.03 (− 0.07; − 0.00) |
| 13 | 187 | − 0.01 (− 0.14; 0.13) | − 0.02 (− 0.05; 0.02) | − 0.02 (− 0.22; 0.18) | − 0.01 (− 0.04; 0.02) |
| > 13 | 125 | Ref | Ref | Ref | Ref |
| p-trend | 601 | 0.06 | 0.61 | 0.24 | 0.14 |
| Age at menarche continuous (per 5 years)f | 601 | 0.16 (− 0.02, 0.33) | 0.01 (− 0.04, 0.05) | − 0.13 (− 0.40, 0.13) | 0.03 (− 0.02, 0.07) |
| Time between menarche and age at first birth, continuous (per 5 years)g | 527 | 0.07 (− 8.0 × 10−3; 0.14) | − 0.01 (− 0.03; 0.01) | − 0.01 (− 0.11; 0.09) | − 9.0 × 10−3 (− 0.02; 0.02) |
| Time since the last pregnancy, continuous (per 5 years)c | 501 | − 0.04 (− 0.12; 0.05) | − 0.02 (− 0.04; 3.8 × 10−3) | 0.07 (− 0.04; 0.19) | − 0.02 (− 0.04; 2.1 × 10−3) |
aFibroglandular tissue represents combined epithelium and stroma
bAdjusted for age (continuous), BMI (continuous), age at menarche (< 12, 12, 13, > 13), a family history of breast cancer (yes/no), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
cAmong parous women only: adjusted for age (continuous), BMI (continuous), age at menarche (< 12, 12, 13, > 13), parity (1, 2, 3, and ≥4 children), age at first child’s birth (<25, 25-29, and ≥30 years), a family history of breast cancer (yes/no), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
dAmong parous women only: adjusted for age (continuous), BMI (continuous), age at first birth (<25, 25-29, and ≥30 years), age at menarche (< 12, 12, 13, > 13), a family history of breast cancer (yes/no), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
eAmong parous women only: adjusted for age (continuous), BMI (continuous), parity (1, 2, 3, and ≥4 children), age at menarche (< 12, 12, 13, > 13), a family history of breast cancer (yes/no), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
fAdjusted for age (continuous), BMI (continuous), parous status (nulliparous, parous), a family history of breast cancer (yes/no), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)
gAmong parous women only: adjusted for age (continuous), BMI (continuous), parity (continuous), a family history of breast cancer (yes/no), NHS cohort (NHSI, NHSII), and alcohol use (none, > 0 to < 5, ≥5 g/day)